Chronic Kidney Disease Clinical Trials in Kansas City, Missouri

5 studies are recruiting for chronic kidney disease in Kansas City, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

   Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine. The kidneys filter waste and fluid from the blood to form urine. In children wit…

   Stage

   Phase 3

   Ages

   1 to 18

   Site

   Children's Mercy Hospital Kansas City - Nephrology, Kansas City, Missouri

   Locations

   151 in total

   Run by

   Bayer

   See if you can join NCT05457283 on ClinicalTrials.gov

2. A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

   This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled by the body in chil…

   Stage

   Phase 3

   Ages

   2 to 17

   Site

   Children's Mercy Hospitals and Clinics, Kansas City, Missouri

   Locations

   93 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07107945 on ClinicalTrials.gov

3. Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

   The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Bloo…

   Stage

   Not phased

   Ages

   0 to 22

   Site

   Children's Mercy Kansas City, Kansas City, Missouri

   Locations

   2 in total

   Run by

   Johns Hopkins Bloomberg School of Public Health

   See if you can join NCT00327860 on ClinicalTrials.gov

4. A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

   The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney function in participants with chronic kidney disease with or without type 2 diabetes, living with overweight or obesity. The participants will either get N…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Clinical Research Consultants, Kansas City, Missouri

   Locations

   147 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT06717698 on ClinicalTrials.gov

5. A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

   This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.

   Stage

   Phase 3

   Ages

   0 to 18

   Site

   Childrens Mercy Hospital, Kansas City, Missouri

   Locations

   43 in total

   Run by

   Amgen

   See if you can join NCT03633708 on ClinicalTrials.gov